Details for New Drug Application (NDA): 209886
✉ Email this page to a colleague
The generic ingredient in BEXAROTENE is bexarotene. There are seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the bexarotene profile page.
Summary for 209886
Tradename: | BEXAROTENE |
Applicant: | Upsher Smith Labs |
Ingredient: | bexarotene |
Patents: | 0 |
Suppliers and Packaging for NDA: 209886
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BEXAROTENE | bexarotene | CAPSULE;ORAL | 209886 | ANDA | Upsher-Smith Laboratories, Inc. | 0832-0285 | 0832-0285-00 | 100 CAPSULE in 1 BOTTLE (0832-0285-00) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 75MG | ||||
Approval Date: | Jul 25, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription